Borland et al. [40] reported that PPARβ/δ had similar antiproliferative activity to PPARγ in melanoma in vitro and in vivo and could have a beneficial effect in the chemoprevention of primary and metastatic melanoma. The gene discussed is PPARG; the disease is melanoma.